N-(4-Benzyloxyphenyl)-2-(toluene-4-sulfonylamino)acetamide

ID: ALA4436814

PubChem CID: 117719069

Max Phase: Preclinical

Molecular Formula: C22H22N2O4S

Molecular Weight: 410.50

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)NCC(=O)Nc2ccc(OCc3ccccc3)cc2)cc1

Standard InChI:  InChI=1S/C22H22N2O4S/c1-17-7-13-21(14-8-17)29(26,27)23-15-22(25)24-19-9-11-20(12-10-19)28-16-18-5-3-2-4-6-18/h2-14,23H,15-16H2,1H3,(H,24,25)

Standard InChI Key:  RIBGZQOQQXQJJA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   40.1497  -16.4965    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.7452  -15.7908    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   39.3362  -16.4939    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.0365  -15.3883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4519  -15.3829    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.1612  -15.7889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8674  -15.3776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5766  -15.7835    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.8643  -14.5604    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.2828  -15.3723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.9892  -15.7803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.6949  -15.3698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.6922  -14.5517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.9780  -14.1459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.2752  -14.5589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0347  -14.5741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3269  -14.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6230  -14.5842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6314  -15.4034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3398  -15.8022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9119  -14.1816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.3978  -14.1395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   46.1076  -14.5445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.1118  -15.3617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4028  -15.7699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4066  -16.5863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.1169  -16.9921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.8248  -16.5755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.8175  -15.7605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  2  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  4 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  4  1  0
 18 21  1  0
 13 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END

Associated Targets(Human)

SRR Tbio Serine racemase (249 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 410.50Molecular Weight (Monoisotopic): 410.1300AlogP: 3.49#Rotatable Bonds: 8
Polar Surface Area: 84.50Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.37CX Basic pKa: CX LogP: 3.80CX LogD: 3.80
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -1.60

References

1.  (2014)  Serine racemase inhibitor, 

Source